Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
Actual shortage: | 30 (23%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 29 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-11 | 2021-06-22 | 131327 |
MINT-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2021-01-11 | 2021-04-05 | 131333 |
MINT-ONDANSETRON | 8MG | TABLET | Resolved | 2021-01-11 | 2021-03-23 | 131330 |
MINT-LACOSAMIDE | 50MG | TABLET | Resolved | 2021-01-11 | 2021-02-23 | 131336 |
MINT-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108295 |
MINT-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108298 |
MINT-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108301 |
MINT-RAMIPRIL | 15.0MG | CAPSULE | Resolved | 2020-08-19 | 2021-01-11 | 122510 |
MINT-FLUOXETINE | 20MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57069 |
MINT-FLUOXETINE | 10MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57064 |
MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2020-08-19 | 2020-11-11 | 122507 |
MINT-CITALOPRAM | 40MG | TABLET | Resolved | 2020-04-27 | 2020-11-11 | 113285 |
MINT-ZOPICLONE | 5MG | TABLET | Resolved | 2020-07-13 | 2020-11-03 | 120139 |
MINT-OLANZAPINE | 5MG | TABLET | Resolved | 2020-08-19 | 2020-10-27 | 122524 |
MINT-OLANZAPINE | 10MG | TABLET | Resolved | 2020-08-19 | 2020-10-27 | 122527 |
MINT-OLANZAPINE | 2.5MG | TABLET | Resolved | 2020-08-19 | 2020-10-27 | 122521 |
MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2020-04-27 | 2020-10-10 | 113281 |
MINT-RISPERIDON | 4.0MG | TABLET | Resolved | 2020-08-19 | 2020-09-21 | 122516 |
MINT-RISPERIDON | 3.0MG | TABLET | Resolved | 2020-08-19 | 2020-09-21 | 122513 |
MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Resolved | 2019-04-08 | 2020-07-13 | 80811 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58286 |
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58283 |
MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |
MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |